Teaching appropriate interactions with pharmaceutical company representatives: The impact of an innovative workshop on student attitudes by Wofford, James L & Ohl, Christopher A
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Medical Education
Open Access Research article
Teaching appropriate interactions with pharmaceutical company 
representatives: The impact of an innovative workshop on student 
attitudes
James L Wofford*† and Christopher A Ohl†
Address: Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA
Email: James L Wofford* - jwofford@wfubmc.edu; Christopher A Ohl - cohl@wfubmc.edu
* Corresponding author    †Equal contributors
Abstract
Background: Pharmaceutical company representatives (PCRs) influence the prescribing habits
and professional behaviour of physicians. However, the skills for interacting with PCRs are not
taught in the traditional medical school curriculum. We examined whether an innovative,
mandatory workshop for third year medical students had immediate effects on knowledge and
attitudes regarding interactions with PCRs.
Methods: Surveys issued before and after the workshop intervention solicited opinions (five point
Likert scales) from third year students (n = 75) about the degree of bias in PCR information, the
influence of PCRs on prescribing habits, the acceptability of specific gifts, and the educational value
of PCR information for both practicing physicians and students. Two faculty members and one PCR
led the workshop, which highlighted typical physician-PCR interactions, the use of samples and gifts,
the validity and legal boundaries of PCR information, and associated ethical issues. Role plays with
the PCR demonstrated appropriate and inappropriate strategies for interacting with PCRs.
Results: The majority of third year students (56%, 42/75) had experienced more than three
personal conversations with a PCR about a drug product since starting medical school. Five percent
(4/75) claimed no previous personal experience with PCRs. Most students (57.3%, 43/75) were not
aware of available guidelines regarding PCR interactions. Twenty-eight percent of students (21/75)
thought that none of the named activities/gifts (lunch access, free stethoscope, textbooks,
educational CD-ROMS, sporting events) should be restricted, while 24.0% (8/75) thought that
students should be restricted only from sporting events. The perceived educational value of PCR
information to both practicing physicians and students increased after the workshop intervention
from 17.7% to 43.2% (chi square, p = .0001), and 22.1% to 40.5% (p = .0007), respectively. Student
perceptions of the degree of bias of PCR information decreased from 84.1% to 72.9% (p = .065),
but the perceived degree of influence on prescribing increased (44.2% to 62.1% (p = .02)).
Conclusions: Students have exposure to PCRs early in their medical training. A single workshop
intervention may influence student attitudes toward interactions with PCRs. Students were more
likely to acknowledge the educational value of PCR interactions and their impact on prescribing
after the workshop intervention.
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Background
Pharmaceutical company representatives (PCRs) influ-
ence the prescribing habits and professional behavior of
physicians [1]. Despite the availability of guidelines
regarding appropriate interactions with PCRs for practic-
ing physicians [2-4], the skills for interacting with PCRs
have not been included as part of the traditional medical
school curriculum.
Physicians in training may be particularly susceptible to
marketing strategies from PCRs. Restricting interactions
between physician in training and PCRs is one approach
to eliminating adverse effects of contacts with PCRs [5].
However, physicians in training will likely deal with such
marketing influences once in practice. The provision of
training or guided experiences in dealing with PCRs seems
a more reasonable educational strategy for producing a
physician who will be aware of the potential conflict of
interest from the profit motive inherent in the pharma-
ceutical and other health related industries. To our knowl-
edge, there is only one published study of an educational
intervention targeting third year medical students on the
subject of appropriate interactions with PCRs [6]. Further-
more, the best means of developing the skills and atti-
tudes for interacting appropriately with PCRs is not well
defined.
We sought to examine whether a single workshop inter-
vention had immediate effects on the attitudes of third
year medical students regarding interactions with PCRs.
The goal of the workshop was to increase the student's
knowledge and awareness of ethical issues surrounding
the PCR encounter, and to improve the students' interac-
tions with representatives by fostering discussion on the
profit motive in pharmaceutical marketing, PCR market-
ing techniques, and appropriate interactions with the
PCR, issues necessary for critical thinking about the
potential conflict of interest. Unique to our intervention
was the participation of a PCR who role played a typical
PCR encounter and who offered a perspective on market-
ing from the perspective of industry. Our findings have
implications for institutions considering strategies for
controlling PCR interactions and for medical educators
seeking to develop curricula for marketing in medicine.
Methods
During the ambulatory internal medicine clerkship of the
third year medical school curriculum, students were
required to attend a ninety minute workshop entitled
"Appropriate Encounters with Pharmaceutical Represent-
atives". These workshops took place three times during
the calendar year 2001 for three different student groups.
To the best of our knowledge, there were no other organ-
ized learning experiences in the medical school curricu-
lum about interactions with pharmaceutical
representatives, either before or during the study period.
We did not seek approval by the institutional review
board for ethical research practice at our institution,
because at that time the study was conducted, approval of
student education projects was considered unnecessary.
Two faculty members interested in the subject (JW, CO),
and a regional manager of pharmaceutical representatives
from a major pharmaceutical company facilitated the
ninety minute workshop. The workshop began by solicit-
ing student opinions regarding the characteristics of typi-
cal interactions with PCRs. After a list of characteristics
was compiled, each characteristic was discussed in more
detail and compared with previous personal experiences
with PCRs. Salient points of the subsequent discussion
included the usefulness of patient assistance programs,
the use of samples and gifts in PCR marketing strategies,
the validity and legal boundaries of information provided
by the PCR, and the ethical and legal aspects of physician-
industry relations. The final segment of the workshop
involved two student volunteers who role played a typical
PCR encounter in the office. After discussion of the first
role play, a second role play between one faculty member
(CO) and the PCR demonstrated desirable characteristics
of the PCR encounter.
A pre-intervention survey handed out and collected prior
to the beginning of the workshop solicited information
about the number of previous personal experiences with
PCRs, and whether the student was previously aware of
guidelines (medical school, federal government, or pro-
fessional society) for appropriate interactions with PCRs.
Using five point Likert scales, the survey solicited student
attitudes about the educational value of PCR information
for practicing physicians and for medical students, the
degree of bias in PCR information, and the degree of
influence of PCRs on prescribing habits. One additional
question solicited the acceptability to students of specific
gifts (lunch access, free stethoscope, textbooks, educa-
tional CD-ROMS, sporting events) from PCRs. A post-
intervention survey with the same attitude questions was
administered and collected as students left the workshop.
The available data comes from three groups – the third, or
last student group of academic year 2000–1 and the first
two student groups of academic year 2001–2.
Students were characterized by gender, age, and number
of previous personal contacts with PCRs (None, 1–3, 4–6,
>6). For the purposes of understanding the Likert scale
responses for student attitudes, we collapsed Likert scores
into three categories – scale responses of 1 or 2 to signify
disagreement, a scale response of 3 to signify neutral, and
a response of 4 or 5 to signify agreement with the attitude
question. We compared student attitudes toward the edu-
cational value of PCR detailing for medical students withBMC Medical Education 2005, 5:5 http://www.biomedcentral.com/1472-6920/5/5
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the perceived value for practicing physicians using the
Pearson chi square test.
The association between previous personal PCR experi-
ence and attitudes about the educational value of PCR
detailing was explored using analysis of variance. We also
compared attitudes before and after the workshop inter-
vention using the Pearson chi square test and a dichoto-
mous variable a response of 4 or 5 (versus 3 or lower) on
the Likert scale.
Results
Student characteristics
A total of 75 students attended one of the three manda-
tory workshops on "Appropriate Encounters with PCRs".
One student did not complete a post-intervention survey.
The mean age of students was 26.4 (± 2.4), and males
(56.1%, n = 41) outnumbered females. Fifty-six percent of
students (42/75) had experienced more than three per-
sonal conversations about a pharmaceutical product with
a PCR since starting medical school. Five percent (4/75)
claimed no previous personal experience with PCRs.
There was no association between the number of PCR
contacts, and either gender, age or time of the academic
year.
Student attitudes toward value of PCR interaction
The pre-intervention survey showed that PCR detailing
was of educational value to 22.1% (18/75) of students
with no perceived difference in educational value to med-
ical students versus that to practicing physicians (chi
square, p = .40). While students agreed that the degree of
bias from PCR information was substantial (86.7%, 65/
75), only 44.0% (33/75) of students felt that pharmaceu-
tical representatives were influential with regard to physi-
cians' prescribing habits. No relationship between
number of previous personal PCR contacts and educa-
tional value to medical students was demonstrated
(ANOVA p = .08)
Awareness of guidelines and attitudes toward gifts
Forty-three percent (32\75) of students reported aware-
ness of available guidelines regarding PCR interactions.
Fifty percent (16/32) of those students reported familiar-
ity with medical school guidelines, 21.8% (7/32) with
federal government guidelines, and 40.6% (13/32) with
professional society guidelines. When asked which drug
company sponsored activities/gifts targeting medical stu-
dents should be restricted, 28.0% of students (21\75)
thought that none of the named activities/gifts (lunch
access, free stethoscope, textbooks, educational CD-
ROMS, sporting events) should be restricted. Twenty-four
percent (8/75) of students thought that only sporting
events should be restricted.
Effect of workshop intervention on student attitudes
Figure 1 shows that the perceived educational value to
both practicing and student physicians increased after the
workshop intervention from 17.7% to 43.2% (chi square,
p = .0001), and 22.1% to 40.5% (p = .0007), respectively.
Fifty-eight percent of students (43/74) and 37.8% (28/
74), respectively, changed their Likert scale response to
the questions on educational value by at least one point
after the workshop intervention (Table 1). Student per-
ceptions of the degree of bias of PCR information
decreased from 84.1% to 72.9% (p = .065), but the per-
ceived degree of influence on prescribing increased
(44.2% to 62.1% (p = .02)). The response to the question
on the degree of bias in PCR detailing changed by at least
one Likert scale point for 17 students (17/74, 23.0%)
(Table 1). The response to the question on the influence
of PCR detailing on prescribing practices changed by at
least one Likert scale point for 34 students (34/75,
46.0%).
Discussion
Professional relationships with PCRs begin early in a phy-
sician's career. Because physicians typically underestimate
the influence of pharmaceutical marketing on prescribing
practices, countering this naivete early is warranted.
Because students do not yet have prescribing privileges,
the effect of PCR detailing on the prescribing decision is
less relevant than how PCR contact shapes professional
values [1]. Several studies have examined perceptions of
the potential influence of PCRs on resident and practicing
physicians [7-13]. However, fewer studies have examined
the views of medical students [6,14,15].
Our data show that students have early exposure to PCRs,
perhaps earlier than previously suspected. Only five per-
cent of third year students at this institution had not yet
experienced PCR detailing, and many had experienced
greater than six such encounters. Although resident physi-
cians understandably have more PCR contacts, on average
at least three PCR encounters per month [11,16], to our
knowledge, there are no studies of comparable data for
medical students.
In this study few students were aware of existing guide-
lines for PCR interactions. Furthermore, students per-
ceived information from PCRs to have educational value,
and a value equivalent to that for practicing physicians.
That students felt no more or less susceptible to marketing
influence than practicing physicians is a marked contrast
to the opinions of many educators that physicians in
training need special protection from marketing influ-
ences [1,2,17].
Several interventions have been proposed for educating
physicians-in-training about pharmaceutical marketingBMC Medical Education 2005, 5:5 http://www.biomedcentral.com/1472-6920/5/5
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practices. Shaughnessy et al described a single brief semi-
nar of marketing concepts followed by regular structured
evaluation of PCR sales presentations throughout the fol-
lowing year [18]. Despite this well organized effort, mean-
ingful educational outcomes were meager for the twelve
residents evaluated. Hopper et al showed that a single
elective forty minute lecture/discussion on ethical and
marketing issues in pharmaceutical promotion was suc-
cessful in improving attitudes and knowledge among res-
idents and faculty [19]. They presented six vignettes to
illustrate marketing techniques related to gifts, guidelines,
and the yield of marketing for pharmaceutical companies.
Vinson et al showed that a fifty minute lecture for first and
second year medical students could have immediate
effects on knowledge as measured by repeat anonymous
survey six weeks later [15]. Palmisano et al described a
ninety minute lecture and role-play with simulated PCRs
to teach analysis of advertising copy and sales techniques,
although no data on educational outcomes were offered
[20]. Most similar to our intervention was this study by
Wilkes and Hoffman who used pharmacists who were
trained to portray PCRs during a one hour seminar target-
ing third year medical students [6]. Designed to promote
critical thinking about appropriate physician-PCR interac-
tions, the single workshop was successful in increasing the
amount of uncertainty students felt about the accuracy
and ethics of standard drug "detailing".
Similar to these interventions, our workshop intervention
targeting third year medical students was a one time inter-
Student attitudes toward PCR detailing before and after workshop intervention Figure 1
Student attitudes toward PCR detailing before and after workshop intervention. Student perception of the educa-
tional value of PCR interactions increased after the intervention at the same time that the perception that PCRs influenced 
prescribing increased. Student perception of the degree of bias decreased slightly after the workshop, but this decrease was 
not statistically significant.BMC Medical Education 2005, 5:5 http://www.biomedcentral.com/1472-6920/5/5
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vention and brief in duration. Our intervention differed in
that the workshop (1) took place during the clinical clerk-
ship year, (2) made use of practicing PCRs and physicians,
and (3) encouraged a distanced but amicable relationship
with the PCR. In contrast to many educators who oppose
PCR contact for trainees, we encouraged respect for the
individual PCR and the success of the pharmaceutical
company's business model. We were concerned enough
about the growing influence of pharmaceutical marketing
on trainees to stage this workshop, but we were careful to
remember our goals of encouraging critical thinking
about the topic rather than simply condemning the PCR
contact. As an example, we emphasized the legal limits
regarding what the PCR could and could not say to the
physician. This may explain, in part, why attitudes toward
PCR information improved after the intervention, at the
same time that perceived degree of influence on prescrib-
ing increased. Teaching students the "rules of the game" in
PCR encounters may explain why students thought that
PCR information had more educational value after the
workshop.
The limitations of this study should be recognized. First,
our survey took place at a single academic medical center
affiliated with a private hospital. Student attitudes might
be different at a state supported institution or at institu-
Table 1: Student attitudes toward PCR detailing before and after workshop intervention
In your opinion, what is the educational value to practicing physicians offered by detailing from pharmaceutical representatives? (1 = No value at all, 
5 = Extremely valuable)
Before-Not Valuable (<3) Before-Neutral (3) Before-Valuable (>3)
A f t e r - N o t  v a l u a b l e  ( < 3 ) 8109
After-Neutral (3) 10 20 3 33
After-Valuable(>3) 2 18 12 32
20 39 15
In your opinion, what is the educational value to medical students offered by detailing from pharmaceutical representatives? (1 = No value at all, 5 
= Extremely valuable)
Before-Not Valuable (<3) Before-Neutral (3) Before-Valuable (>3)
After-Not valuable (<3) 13 0 0 13
After-Neutral (3) 8 19 4 31
After-Valuable(>3) 6 10 14 30
27 29 18
What is you perception of the degree of bias in the information provided by pharmaceutical representatives detailing to practicing physicians? (1 = 
Not at all biased, 5 = Totally biased)
Before-Not Biased (<3) Before-Neutral (3) Before-Biased (>3)
A f t e r - N o t  b i a s e d  ( < 3 ) 0112
After-Neutral (3) 0 6 12 18
After-Biased(>3) 0 3 51 54
01 0 6 4
How influential are pharmaceutical representatives with regard to physicians' prescribing habits? (1 = Not at all influential, 5 = Very influential)
Before-Not Influential (<3) Before-Neutral (3) Before-Influential (>3)
After-Not influential 
(<3)
2215
After-Neutral (3) 7 11 5 23
After- Influential (>3) 2 17 27 36
11 30 33BMC Medical Education 2005, 5:5 http://www.biomedcentral.com/1472-6920/5/5
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tions where there are restrictions on the activities of PCRs.
Second, students may have answered the post-interven-
tion survey in a socially desirable manner. Respect for the
PCR and the business model was presented as a balanced
perspective toward marketing in medicine. Third, how
immediate changes in student perceptions will ultimately
translate into durable attitude changes and prescribing
practices was not a goal of this study. We are not naïve
enough to be certain that a one time intervention on any
subject matter related to ethical issues will change student
attitudes in a way that is durable. However, our goal as
educators should be to make the students think critically,
and demonstrating self-reported attitude changes is a nec-
essary first step toward more durable change.
Some academic institutions have chosen to ban PCRs
from the academic learning environment. McCormick et
al showed that restricting access to PCRs during residency
training was associated with less informational depend-
ence on the PCR and a decreased frequency of PCR contact
after training [5]. Underlying such a restrictive policy is
the idea that trainees are not able and/or educable to resist
the marketing tactics of PCRs. In contrast, our approach is
based on the opinion that learning the skills for interact-
ing appropriately with PCRs should not be delayed until
a physician has entered practice, and that banning PCRs
may simply extend the period of naivete for physicians in
training [14]. Not only does such an omission in the cur-
riculum miss the opportunity to teach physicians about
professional relationships surrounding the business
model. It also ignores the cost containment needs of the
academic medical center and prospective employers.
The challenge for medical educators is how to incorporate
this increasingly important knowledge domain into train-
ing programs. What aspects of marketing strategy need to
be taught and how? The growing emphasis on social jus-
tice and professionalism should encourage the appropri-
ate distance from and respect for marketing pressures in
medicine and add support for this curricular element in
medical education [21]. Our model suggests the possibil-
ity of a partnership between the pharmaceutical industry
and educators in better preparing phsyicians in training
for marketing in medicine. While pharmaceutical compa-
nies are the current target of criticism of commercialism in
medicine, other services (durable medical equipment,
herbal/nutritional supplements, new medical technolo-
gies) are all accompanied by marketing pressures that
physicians will have to factor into clinical decision
making.
Conclusions
Medical students have exposure to PCRs early in their
medical education, at least in this setting. Students per-
ceived information from PCRs to have moderate educa-
tional value, and a value equivalent to that for practicing
physicians. A brief workshop intervention can have a
measurable immediate effect on student attitudes.
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